https://www.valdig.eu/project/splanchnic-vein-thrombosis-and-or-budd-chiari-syndrome-after-sars-cov-2-vaccination/2025-01-31T15:06:39+01:00https://www.valdig.eu/project/covid-19-vaccine-efficacy-and-safety-in-patients-with-vascular-liver-disease/2025-01-31T15:07:15+01:00https://www.valdig.eu/project/splanchnic-vein-thrombosis-in-patients-with-covid-19-infection/2025-01-31T15:07:37+01:00https://www.valdig.eu/project/international-registry-of-congenital-porto-systemic-shunts-ircpss/2022-06-20T17:10:19+02:00https://www.valdig.eu/project/abdominal-surgery-in-patients-with-chronic-extra-hepatic-portal-vein-obstruction/2025-01-31T15:08:58+01:00https://www.valdig.eu/project/long-term-outcome-of-patients-with-budd-chiari-syndrome/2025-01-31T15:08:42+01:00https://www.valdig.eu/project/percutaneous-portal-vein-recanalization-using-self-expandable-nitinol-stents-in-patients-with-non-cirrhotic-non-tumoral-portal-vein-occlusion/2025-01-31T15:08:23+01:00https://www.valdig.eu/project/development-of-portal-hypertension-after-acute-portal-vein-thrombosis-a-long-term-follow-up-study/2025-01-31T15:07:59+01:00https://www.valdig.eu/project/menopause-female-hormones-and-psvd/2023-06-26T16:14:23+02:00https://www.valdig.eu/project/natural-history-of-portosinusoidal-vascular-disease-psvd-and-liver-transplantation/2025-01-31T15:09:29+01:00https://www.valdig.eu/project/medically-assisted-reproduction-in-women-with-vascular-liver-diseases/2022-06-20T17:15:24+02:00https://www.valdig.eu/project/valdig-database-and-registry/2022-06-20T17:18:29+02:00https://www.valdig.eu/project/liver-and-spleen-stiffness-by-2d-shear-wave-elastography-to-detect-porto-sinusoidal-vascular-liver-disorder-in-patients-with-signs-of-portal-hypertension/2022-09-15T07:16:30+02:00https://www.valdig.eu/project/vall-dhebron-university-hospital-research-ethics-committee-with-medicines-and-research-project-commission-report/2023-01-16T13:44:09+01:00https://www.valdig.eu/project/diagnosing-and-exploring-portosinusoidal-vascular-disorder-using-artificial-intelligence-and-reverse-engineering/2023-06-23T10:05:18+02:00https://www.valdig.eu/project/international-registry-for-pulmonary-vascular-complications-of-liver-disease/2023-06-07T09:31:47+02:00https://www.valdig.eu/project/study-protocol-the-natural-history-of-early-porto-sinusoidal-vascular-disorder/2025-01-31T15:05:54+01:00https://www.valdig.eu/project/prevalence-dynamics-and-clinical-implications-of-sarcopenia-in-patients-with-portosinusoidal-vascular-liver-disorder/2025-01-31T15:05:03+01:00https://www.valdig.eu/project/prevalence-and-progression-of-sarcopenia-and-malnutrition-in-patients-with-acute-and-chronic-non-cirrhotic-non-tumoral-portal-vein-thrombosis/2025-01-31T15:05:31+01:00https://www.valdig.eu/project/performance-of-spleen-stiffness-measurement-by-vibration-controlled-transient-elastography-to-rule-out-high-risk-varices-in-patients-with-chronic-extrahepatic-portal-vein-obstruction-without-cirrhosis/2025-01-31T15:04:42+01:00https://www.valdig.eu/project/role-of-liver-transplantation-for-sinusoidal-obstruction-syndrome-following-hematopoietic-stem-cell-transplantation/2025-01-31T15:04:18+01:00https://www.valdig.eu/project/hyperdynamic-circulation-and-activation-of-vasoactive-systems-in-patients-with-non-cirrhotic-portal-vein-thrombosis-prevalence-risk-factors-and-impact-on-the-outcome/2025-01-31T15:03:53+01:00https://www.valdig.eu/project/characterization-of-porto-sinusoidal-vascular-disease-in-patients-with-common-variable-immunodeficiency/2025-01-31T15:03:29+01:00https://www.valdig.eu/project/throm-ped-registry-thrombosis-of-the-hepatic-vessels-incl-portal-vein-thrombosis-and-hepatic-vein-thrombosis-with-or-without-underlying-liver-disease/2025-01-31T15:03:02+01:00https://www.valdig.eu/project/dynamic-measurement-of-liver-and-spleen-stiffness-measurement-to-predict-outcomes-in-patients-with-porto-sinusoidal-vascular-disorder/2025-01-31T15:02:28+01:00https://www.valdig.eu/project/porto-sinusoidal-vascular-disorder-associated-with-systemic-sclerosis-a-case-control-study/2024-09-15T09:01:21+02:00https://www.valdig.eu/project/porto-sinusoidal-vascular-disorder-occurring-post-liver-transplantation/2025-01-31T15:02:04+01:00https://www.valdig.eu/project/transjugular-intrahepatic-portosystemic-shunt-in-porto-sinusoidal-vascular-disorder/2024-12-08T13:37:13+01:00https://www.valdig.eu/project/prognostic-value-of-spleen-stiffness-measurement-using-vibration-controlled-transient-elastography-vcte-post-recanalization-of-portal-vein-in-chronic-non-cirrhotic-extrahepatic-portal-vein-obstructi/2024-12-18T11:22:04+01:00https://www.valdig.eu/project/cost-action-euro-valdi-net/2025-02-02T12:04:33+01:00https://www.valdig.eu/project/vascular-liver-diseases-in-transgender-individuals-undergoing-gender-affirming-hormone-therapy-a-european-multicentre-observational-study/2026-01-29T09:44:09+01:00https://www.valdig.eu/project/bile-acid-profiling-in-porto-sinusoidal-vascular-disorder-psvd/2025-05-04T12:32:56+02:00https://www.valdig.eu/project/portal-vein-recanalization-before-liver-transplantation/2026-04-17T14:37:21+02:00https://www.valdig.eu/project/redefining-the-management-of-portal-cholangiopathy-therapeutic-strategies-and-long-term-outcomes/2026-04-21T12:11:21+02:00https://www.valdig.eu/project/combined-cerebral-and-splanchnic-vein-thrombosis-a-retrospective-cohort-study/2026-02-06T10:39:03+01:00https://www.valdig.eu/project/effectiveness-and-safety-of-anticoagulation-in-porto-sinusoidal-vascular-disorder-associated-portal-vein-thrombosis-a-multicenter-retrospective-study/2026-04-17T13:08:46+02:00https://www.valdig.eu/project/multicenter-study-on-the-efficacy-and-safety-of-post-liver-transplant-anticoagulation-in-recipients-with-cirrhotic-non-tumoral-portal-vein-thrombosis/2026-04-17T13:14:46+02:00https://www.valdig.eu/project/extended-secondary-prevention-of-splanchnic-vein-thrombosis-an-observational-study-space-val-study/2026-05-12T14:47:39+02:00https://www.valdig.eu/project/acute-kidney-injurie-in-hospitalized-patients-with-porto-sinusoidal-vascular-disorder-and-ascites/2026-09-21T15:19:58+02:00https://www.valdig.eu/project/congenital-hepatic-fibrosis-from-childhood-to-adulthood-natural-history-and-long-term-outcomes-accronym-life-chf/2026-06-26T11:54:11+02:00